Law amending Law 29885, LAW DECLARING THE CREATION OF THE Universal NEONATAL SCREENING PROGRAM TO BE OF NATIONAL INTEREST. It includes, among the tests that form part of the Screening, the Cystic Fibrosis screening.
- Cystic fibrosis patients receive triple therapy medication free of charge for the first time
- Minsa finalized the acquisition of high-cost medication to improve the quality of life of patients with cystic fibrosis
- ALYFTREK modulator approved in the United States, United Kingdom, European Union and Canada
- Approval of Law 29698 on Rare and Orphan Diseases: Law that declares the treatment of people suffering from rare or orphan diseases to be of National Interest and preferential attention.
- Approval of Law 31738: LAW THAT MODIFIES LAW 29698 LAW THAT DECLARES THE TREATMENT OF PEOPLE SUFFERING FROM RARE OR ORPHAN DISEASES TO BE OF NATIONAL INTEREST AND PREFERENTIAL ATTENTION